| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $18.6M | -1.7% | +18.4% |
| Cost of Revenue | $3.9M | -3.6% | +13.8% |
| Gross Profit | $14.6M | -1.2% | +19.7% |
| R&D Expense | $361K | -6.0% | +30.3% |
| SG&A Expense | $10.5M | -2.8% | +7.2% |
| Operating Income | $3.8M | +4.0% | +76.0% |
| Pre-tax Income | $3.9M | +3.7% | +69.4% |
| Income Tax | $863K | -10.8% | +120.7% |
| Net Income | $3.0M | +8.8% | +58.8% |
| EPS (Basic) | $0.37 | +12.1% | +68.2% |
| EPS (Diluted) | $0.35 | +9.4% | +66.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $17.0M | +23.2% | +11.5% |
| Accounts Receivable | $28.3M | +7.6% | +20.5% |
| Inventory | $3.3M | -4.7% | +11.0% |
| Current Assets | $50.2M | +10.2% | +13.7% |
| Total Assets | $59.5M | +8.3% | +13.4% |
| Current Liabilities | $10.2M | +9.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $6.7M | — | — |
| Capital Expenditures | $1.0M | — | — |
| Investing Cash Flow | -$1.1M | — | — |
| Financing Cash Flow | -$3.9M | — | — |
| Free Cash Flow | $5.6M | — | — |
| +20.2% |
| Total Liabilities | $10.3M | +8.8% | +21.1% |
| Stockholders' Equity | $49.2M | +8.2% | +11.9% |